News Focus
News Focus
icon url

exwannabe

07/04/25 3:06 PM

#774193 RE: ATLnsider #774188

Hi ATL. Of course you will never understand the core issue as you keep your ears closed to anybody who disagrees with you.

It is clear the lack of patient level data for the ECA is a huge issue. Both FDA and MHRA guidences call it out. Other issues exist, but that is just overkill.

But for those who fail to understand the core issues, consider this.

NWBO announced 7 years ago that the trial was complete. All they needed to do was wrap it up and get approved. And for 7 years you ass clowns have been saying how all these new RA programs were designed to get -L approved fast.

Tool on ...
icon url

dennisdave

07/04/25 3:26 PM

#774197 RE: ATLnsider #774188

Manibiotech. I have searched the entire guidance document. I don’t see the alleged quote you supposedly quoted.

I was able to find that quote under 30 seconds, it just comes to show how bad you are in biotech due diligence

https://www.fda.gov/media/164960/download?utm_source=chatgpt.com